By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Market Opportunity – Cell Therapy Research
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Market Opportunity – Cell Therapy Research
Technology

Market Opportunity – Cell Therapy Research

PatrickDriscoll
PatrickDriscoll
Share
2 Min Read
SHARE
Neurological disorders or injuries are those affecting the central nervous system (brain and spinal cord) or peripheral nervous system (PNS). Neurodegenerative diseases primarily involve neural deterioration. Causes can include: traumatic brain, spinal cord or nerve injury, genetic disorders, congenital abnormality or disorders, infections, and lifestyle or environmental health problems (including malnutrition).
Structural, biochemical or electrical abnormalities in the brain or spinal cord, or in the nerves leading to or from them, can result in symptoms such as paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. Disorders in neurology that represent targets of cell therapy research include stroke, Parkinson’s Disease, Alzheimer’s Disease, epilepsy, traumatic brain injury, central nervous system and spinal cord diseases — amyotropic lateral sclerosis (Lou Gehrig’s Diseas), multiple sclerosis, neuromuscular/muscular dystrophy). Considering only the numbers of Americans, there is a large population of potential patients:
  • Stroke: 700,000 per year
  • Parkinson’s: 4.5 million prevalence
  • Alzheimer’s: 1 million prevalence
  • Epilepsy: 200,00 per year
  • Traumatic brain injury: 1.4 million prevalence
  • Central nervous system and spinal cord disease: 1 million prevalence

Companies with active product development for cell therapy in neurological applications include: Aastrom Bioscience Inc., Aeolus Pharmaceuticals, Aldagen, Inc., Athersys, Inc., BeFutur Biotechnologies, BrainStorm Cell Therapeutics, Inc., co.don AG, ES Cell International, Geron Corporation, Innogenetics, Integra LifeSciences Inc., Living Cell Technologies Ltd., Medtronic, Neuralstem, Inc., NeuroGeneration, Inc., NeuroNova AB, Osteotech, Pluristem Therapeutics, Inc., Polyganics BV, ProNeuron Biotechnologies, Inc., ReInnervate Ltd., ReNeuron Ltd., Sernova Corp., Stem Cell Pharma Inc., StemCells Inc., Targeted Genetics Corporation, TEI Biosciences Inc., Transition Therapeutics Inc, and TriStem Corporation. Data on cell and tissue engineering therapy markets and products under development is provided in MedMarket Diligence Report #S520, “Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.”

TAGGED:cell therapy researchneurology
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Technology Solutions for Seniors Still Need Work

May 31, 2011
Networking at Health 2.0 Seattle
Technology

Health 2.0 Seattle Meetup: How to Build Solutions in Healthcare

March 26, 2014
BusinessMobile HealthNewsRemote DiagnosticsTechnology

Connectivity In Medical Devices Provides Critical Information in Real Time

December 28, 2011

Imagine: EMRs Without Big Brother

July 1, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?